tiprankstipranks
Trending News
More News >
TG Therapeutics (TGTX)
NASDAQ:TGTX
US Market

TG Therapeutics (TGTX) Income Statement

Compare
2,097 Followers

TG Therapeutics Income Statement

Last quarter (Q2 2025), TG Therapeutics's total revenue was $141.15M, an increase of 92.13% from the same quarter last year. In Q2, TG Therapeutics's net income was $28.19M. See TG Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 329.00M$ 233.66M$ 2.79M$ 6.69M$ 152.00K
Gross Profit
$ 290.52M$ 219.11M$ 2.52M$ 5.90M$ 152.00K
Operating Expenses
$ 248.59M$ 198.90M$ 220.84M$ 350.67M$ 273.75M
Depreciation and Amortization
$ 280.00K$ 423.00K$ 515.00K$ 494.00K$ 374.00K
EBITDA
$ 49.90M$ 26.10M$ -213.11M$ -341.97M$ -272.68M
Operating Income
$ 41.93M$ 20.63M$ -218.32M$ -344.77M$ -273.59M
Other Income/Expenses
$ -16.34M$ -7.57M$ -5.50M$ -3.33M$ -5.79M
Pretax Income
$ 25.59M$ 13.06M$ -223.81M$ -348.10M$ -279.38M
Net Income
$ 23.38M$ 12.67M$ -223.81M$ -348.10M$ -279.38M
Per Share Metrics
Basic EPS
$ 0.16$ 0.09$ -1.46$ -2.63$ -2.42
Diluted EPS
$ 0.15$ 0.09$ -1.46$ -2.63$ -2.42
Weighted Average Shares Outstanding
145.32M 141.96M 135.41M 132.22M 115.33M
Weighted Average Shares Outstanding (Diluted)
160.34M 148.51M 135.41M 132.22M 115.33M
Currency in USD

TG Therapeutics Earnings and Revenue History